| scholarly article | Q13442814 |
| P50 | author | Rangan Srinivasaraghavan | Q85219289 |
| P2093 | author name string | Jharna Mandal | |
| Parameswaran Narayanan | |||
| Niranjan Biswal | |||
| Balasubramaniam Banupriya | |||
| P2860 | cites work | Microaspiration in intubated critically ill patients: diagnosis and prevention. | Q37890440 |
| Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients | Q39487652 | ||
| Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials | Q39918513 | ||
| Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). | Q43461341 | ||
| Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children | Q44553242 | ||
| Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial | Q47187980 | ||
| Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. | Q47212470 | ||
| In vitro evaluation of single- and multi-strain probiotics: Inter-species inhibition between probiotic strains, and inhibition of pathogens | Q50026266 | ||
| Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial | Q57259604 | ||
| Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995 | Q71078937 | ||
| Risk Factors and Outcome of Nosocomial Infections: Results of a Matched Case-control Study of ICU Patients | Q74489991 | ||
| Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial | Q80286495 | ||
| Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial | Q80785665 | ||
| A prospective randomised trial of probiotics in critically ill patients | Q81562015 | ||
| Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients | Q21195017 | ||
| Probiotics for preventing ventilator-associated pneumonia | Q24193079 | ||
| Probiotics for the prevention of pediatric antibiotic-associated diarrhea | Q24235039 | ||
| Probiotics for treating acute infectious diarrhoea | Q24236704 | ||
| Probiotics in human medicine | Q24540394 | ||
| Tolerance, Safety, and Effect on the Faecal Microbiota of an Enteral Formula Supplemented With Pre‐ and Probiotics in Critically Ill Children | Q28244068 | ||
| Probiotic use in clinical practice: what are the risks? | Q28245049 | ||
| The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention | Q28252577 | ||
| Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial | Q33440895 | ||
| Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial | Q34268939 | ||
| Nosocomial infections in pediatric intensive care units | Q34480047 | ||
| Probiotics for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of high-quality randomized controlled trials | Q35075628 | ||
| Safety of probiotics: comparison of two popular strains | Q35128833 | ||
| Cochrane in context: probiotics for prevention of necrotizing enterocolitis in preterm infants | Q35263336 | ||
| Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity | Q35356530 | ||
| Current status of bacterial translocation as a cause of surgical sepsis | Q35982636 | ||
| Ventilator-associated pneumonia in adults in developing countries: a systematic review | Q37173031 | ||
| Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions | Q37828325 | ||
| P433 | issue | 4 | |
| P921 | main subject | pneumonia | Q12192 |
| probiotics | Q1816730 | ||
| mechanical ventilation | Q3766250 | ||
| ventilator | Q813243 | ||
| P304 | page(s) | 677-685 | |
| P577 | publication date | 2015-02-24 | |
| P1433 | published in | Intensive Care Medicine | Q15749164 |
| P1476 | title | Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial | |
| P478 | volume | 41 |
| Q51535288 | Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial |
| Q64112662 | Fighting AMR in the Healthcare Environment: Microbiome-Based Sanitation Approaches and Monitoring Tools |
| Q47424163 | Focus on paediatrics. |
| Q40147387 | Hygiene: microbial strategies to reduce pathogens and drug resistance in clinical settings |
| Q40451999 | Preoperative Staphylococcus aureus Carriage and Risk of Surgical Site Infection After Cardiac Surgery in Children Younger than 1 year: A Pilot Cohort Study. |
| Q64892543 | Probiotic Lactobacillus casei Shirota improves efficacy of amoxicillin-sulbactam against childhood fast breathing pneumonia in a randomized placebo-controlled double blind clinical study. |
| Q43788892 | Probiotic prophylaxis to prevent ventilator-associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial--response to comments by Saptharishi et al. |
| Q40301318 | Probiotic use in an infectious disease setting |
| Q47142541 | Probiotics for Preventing Ventilator-Associated Pneumonia in Mechanically Ventilated Patients: A Meta-Analysis with Trial Sequential Analysis. |
| Q26747748 | Probiotics in critically ill children |
| Q41004993 | Should pediatric infectious diseases physicians be proponents of probiotics? |
| Q90444769 | Synbiotics for prevention of ventilator-associated pneumonia: a probiotics strain-specific network meta-analysis |
| Q38626112 | The Fragility Index in a Cohort of Pediatric Randomized Controlled Trials |
| Q38972102 | The development of probiotics for women's health |
| Q44121685 | Ventilator-associated pneumonia or bacterial colonization of the airway, what do probiotics decrease? |
Search more.